Digital Diagnostics, formerly IDx, Expands Global Impact of Healthcare Autonomous AI with Acquisition of 3Derm Systems, Inc.

23 August, 2020

Healthcare access and inequity challenges have been exacerbated by the COVID-19 pandemic; members of at-risk populations around the world are increasingly delaying important specialist care. Today Digital Diagnostics Inc., a pioneering global healthcare autonomous artificial intelligence (AI) company formerly known as IDx, announces it has acquired 3Derm Systems, Inc. of Boston, MA. This acquisition makes Digital Diagnostics the global leader in healthcare autonomous AI, where it is the sole holder of autonomous AI healthcare systems that are De Novo authorized by the U.S. Food & Drug Administration (FDA), enabling the company to close more care gaps widened by COVID-19.

Related News
3Derm October Newsletter
It's that time of year in Boston when you have 75 degree weekends followed immediately by 35 degree Mondays. We get it, Beantown is not an ideal destination at the moment. HOWEVER, this week our team will be opening up our office to advisors, investors, and other industry minds to hold a week of BrainTrust™ brainstorming sessions that cover Product Strategy, Workflow and Operations, Future Technology, and Marketing and Productizing. Video conference attendees are welcome. Read Full Release